U.S. Luxury Stock News

Why DuPont de Nemours (DD) is on investors’ radar today Recent share performance has put DuPont de Nemours (DD) back in focus. The stock has shown a 5.8% decline over the past month and an 11.3% gain in the past 3 months. See our latest analysis for DuPont de Nemours. At a share price of US$45.48, DuPont de Nemours has seen short term share price pressure with a 30 day share price return of a 5.8% decline, while longer term momentum is reflected in an 11.3% year to date share price return and...

In late March and early April 2026, Vishay Intertechnology reported quarterly results with revenue rising 12.1% year on year but adjusted operating income coming in below expectations, while also launching an Automotive Grade photovoltaic MOSFET driver and a compact high-accuracy linear position sensor for demanding industrial and mobility applications. The new VODA1275 MOSFET driver and 40 LHE position sensor highlight Vishay’s push into higher-value automotive electrification and precision...

In late March 2026, JPMorgan downgraded Scotts Miracle-Gro to Neutral, citing rising input costs tied to geopolitical conflict, even as the company reaffirmed its fiscal 2026 guidance and highlighted that most key commodities were already locked in and largely sourced domestically. At the same time, Scotts Miracle-Gro is pushing ahead with a planned Hawthorne divestiture, expanded marketing and an approved share repurchase program, underscoring management’s confidence in its longer-term...

Targa Resources recently reported past fourth-quarter 2025 earnings of US$2.51 per share, beating analyst expectations and helping deliver a record full-year adjusted EBITDA of US$4.96 billion, supported by higher Permian Basin volumes and effective marketing. The company also outlined 2026 adjusted EBITDA guidance of US$5.4 billion to US$5.6 billion and US$2.5 billion in expansion capital spending, underscoring its commitment to growth-oriented infrastructure investment. We’ll now examine...

Viatris (VTRS) came under pressure after its experimental eye treatment MR-139 failed to meet primary endpoints in two consecutive Phase III trials for blepharitis, a setback that weighed on sentiment. See our latest analysis for Viatris. The share price reaction to the MR-139 trial failure comes after a mixed stretch, with a 30 day share price return of 9.74% offset by a 90 day share price return of 7.87%, while the 1 year total shareholder return of 72.38% and 3 year total shareholder...

Why Arcosa Stock Is Drawing Investor Attention Now Arcosa (ACA) has come onto investor radars after its recent share performance, with a small daily decline, modest gains over the past week, and mixed moves over the past month and past 3 months. For anyone tracking industrial and infrastructure related names, this kind of short term volatility can be a prompt to look more closely at what you are actually getting in terms of business mix, recent financial results, and valuation signals. See...

In late March 2026, Huntington Bancshares’ board declared quarterly cash dividends on its 5.70% Series I and 5.50% Series L Non-Cumulative Perpetual Preferred Stock, with payments scheduled for May 20 and June 1, 2026, to shareholders of record as of April 30 and May 15, respectively. Together with Huntington’s move into a tokenized deposit network and a new SEI wealth platform, these preferred dividends highlight the bank’s focus on modernizing its infrastructure while continuing consistent...

In March 2026, Power Integrations launched its TOPSwitchGaN flyback IC family, using PowiGaN technology to push flyback converter power capability up to 440 W while improving efficiency, cutting thermal requirements, and lowering system complexity and cost for applications like high-end appliances, e-bike chargers, and industrial power supplies. This innovation expands the practical range of a widely used power-supply architecture, potentially making it easier for equipment makers to meet...

Contract win reframes Vericel’s setup for investors Vericel (VCEL) recently secured a US$196.87 million contract with the Health and Human Services department, covering procurement of its FDA approved enzymatic debridement product and development of a next generation version. See our latest analysis for Vericel. The contract news has arrived at a time when Vericel’s short term share price return has picked up, with a 1 day move of 4.85% and a 7 day gain of 10.77%. This is the case even though...

In March 2026, KeyBanc initiated coverage on NiSource Inc. with an Overweight rating, joining several firms that recently reiterated positive views on the regulated utility. Analysts are emphasizing NiSource’s exposure to growing data center power needs and supportive regulation, while still flagging its elevated debt burden and modest interest coverage. Next, we’ll examine how this fresh analyst optimism around data center-driven demand and regulation could reshape NiSource’s existing...

Provident Financial Services (PFS) is back on investors' radar after solid quarterly results, a 7.9% stock move in recent months, and fresh hires in wealth management, along with a new Head of Investor Relations. See our latest analysis for Provident Financial Services. The 7.9% share price move in recent months sits within a steadier pattern, with a 90 day share price return of 7.85% and a 1 year total shareholder return of 39.79%. This hints that momentum has been building as quarterly...

Event driven moves at Centerspace Land & Buildings recently lifted its stake in Centerspace (CSR) to 9.19%, as the REIT also announced the retirement of board member Emily Nagle Green and declared its latest quarterly dividend. See our latest analysis for Centerspace. Despite the latest $59.90 share price seeing a 3.67% 1 day share price return, Centerspace’s 30 day share price return of 3.94% and year to date share price return of 10.56% suggest momentum has been fading, even as the 3 year...

Plains GP Holdings (PAGP) recently filed a shelf registration for up to US$938.9 million of Class A shares, giving the company flexibility to raise equity capital that could affect future dilution and investor sentiment. See our latest analysis for Plains GP Holdings. At a share price of US$24.06, Plains GP Holdings has logged a 90 day share price return of 23.96% and a 1 year total shareholder return of 26.46%. The new US$938.9 million shelf registration gives context to this recent momentum...

Pomerantz LLP is investigating Encompass Health Corporation after a July 15, 2025 New York Times report alleged below-average safety outcomes and serious patient care errors at some of its for-profit hospitals, raising questions about potential securities law violations and business practices. This clash between heightened legal and reputational scrutiny and ongoing confidence from Wall Street analysts creates an unusual tension in how investors may assess Encompass Health’s long-term...

On March 27, 2026, Lincoln National Corporation entered into an unsecured, third amended and restated credit agreement with a bank syndicate led by Bank of America, providing up to US$2.00 billion in borrowing and letters of credit capacity through March 27, 2031, with fees tied to credit ratings and ongoing financial covenants. This long-dated, covenant-driven facility underscores lenders’ confidence in Lincoln National’s balance sheet discipline and gives the company meaningful financial...

Thermo Fisher Scientific (TMO) has been active on the product front, rolling out the Gibco CTS Compleo Fill and Finish System, the CHOvantage GS Cell Line Development Kit and the Glacios 3 Cryo TEM in quick succession. See our latest analysis for Thermo Fisher Scientific. Despite the string of product launches and recent collaboration news, Thermo Fisher Scientific’s 90 day share price return of 17.05% and year to date share price return of 17.05% point to fading momentum, even though the 1...

In recent sessions, Sunrun reported ongoing losses alongside expectations for a small per‑share loss and higher revenue, while also completing a US$431 million securitization of residential solar assets and drawing fresh analyst support. This combination of stronger sector sentiment, expanded financing capacity, and upgraded analyst views has sharpened attention on how effectively Sunrun can convert its growing asset base into sustainable cash generation. Next, we’ll examine how the latest...

Why Warrior Met Coal (HCC) is on investors’ radar Warrior Met Coal (HCC) has drawn attention after a recent move in its share price, with the stock closing at $94.89 and showing mixed returns over the past week, month and past 3 months. See our latest analysis for Warrior Met Coal. The recent 3.25% 1 day share price return and 15.8% 1 month share price return come after a very large 5 year total shareholder return of more than 7x. This suggests momentum has been building over both shorter and...

Alnylam Pharmaceuticals (ALNY) has drawn fresh attention after presenting extensive cardiovascular data at ACC.26. The company highlighted vutrisiran in amyloidosis and zilebesiran in hypertension, alongside new efforts to improve ATTR-CM diagnosis and care coordination. See our latest analysis for Alnylam Pharmaceuticals. The recent ACC.26 data and ATTR-CM care initiatives have arrived after a sharp 90 day share price return decline of 20.32%, even as the 1 year total shareholder return sits...

Trigger event and business mix shift Houlihan Lokey (HLI) is back in focus after recent commentary highlighted a slowdown in its restructuring work, driven by improving macro conditions and lower interest rates, alongside stronger momentum in M&A and valuation advisory. See our latest analysis for Houlihan Lokey. At a share price of $141.32, Houlihan Lokey has seen pressure in recent months, with a 30 day share price return of 12.82% and a 90 day share price return of 19.86%, even as its 5...

In recent weeks, National Vision Holdings has faced pressure after SEC filings showed Vanguard reporting zero beneficial ownership following an internal realignment, alongside Engle Capital’s full liquidation of its stake and increased insider share sales amid concerns about valuation and debt levels. This wave of institutional exits and insider selling is prompting investors to reassess how sensitive National Vision’s business model may be to balance sheet and ownership changes. We’ll now...

Why Global-E Online is back on investors’ radar Global-E Online (GLBE) is drawing fresh attention after a cluster of upbeat analyst reports highlighted its role in cross-border ecommerce, strong gross merchandise volume trends, and ongoing business momentum. Brokerage firms including BofA Securities, UBS, Citizens, and Zacks have recently weighed in on the company, with coverage initiations, reinstated ratings, and upgraded earnings forecasts helping to reshape how investors are looking at...

BJ’s Wholesale Club Holdings has appointed Stephanie Reibling as Executive Vice President and Chief Merchandising Officer, effective April 1, 2026, to lead its merchandising transformation and category growth efforts. Reibling’s deep background at Sam’s Club, Walmart and Gap Inc. introduces fresh merchandising expertise that could influence how BJ’s competes in warehouse retail. We’ll now examine how Reibling’s appointment as Chief Merchandising Officer may reshape BJ’s investment narrative...

Analyst sentiment and value angle behind Deluxe stock’s recent attention Recent analyst upgrades and improved sentiment on Deluxe (DLX) have pushed the stock into the spotlight, as earnings expectations improve and valuation metrics compare favorably with many peers in the Business Services space. See our latest analysis for Deluxe. At a share price of US$27.67, Deluxe has seen a 24.70% year to date share price return and a 93.51% total shareholder return over one year, suggesting recent...